Reactin Plus News

29 Aug 202612:05 am

Regulation29 Aug 2026 · 12:05 am12:05 am

Maharashtra FDA Cancels Cipla Unit's Drug Licence for Reactin Plus Irregularities

The Maharashtra FDA, led by Tukaram Mundhe, canceled a Cipla unit's drug license for Reactin Plus due to irregularities found during a June inspection, specific

28 Aug 20269:30 pm

pharmaceuticals28 Aug 2026 · 9:30 pm9:30 pm

Create visual

Maharashtra FDA Revokes Cipla Pune Unit's Drug Licence for Reactin Plus Violations

The Maharashtra Food and Drug Administration has revoked Cipla's drug license for its Pune unit due to violations in packaging and storage practices, specifical

Reactin Plus News

#Reactin Plus

Maharashtra FDA Cancels Cipla Unit's Drug Licence for Reactin Plus Irregularities

Maharashtra FDA Revokes Cipla Pune Unit's Drug Licence for Reactin Plus Violations

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs